Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
InflaRx
Biotech
Abbvie's president adds COO title—Chutes & Ladders
AbbVie's president named COO. Emergent CEO Kramer retires a second time. Dunsire retires from Lundbeck after record quarter.
Max Bayer
,
Gabrielle Masson
Jun 30, 2023 9:30am
InflaRx to take failed COVID treatment to FDA anyway
Jul 26, 2022 11:20am
EuroBiotech Report—Lilly-CureVac, AstraZeneca-Brexit and more
Oct 19, 2017 11:21am
InflaRx snags $55M for inflammatory, autoimmune trials
Oct 13, 2017 9:47am
German startup raises $34M for first-in-class complement inhibitor
Jul 21, 2016 2:30pm
